Clinical trial R-IMMUNE
A Phase IB/II study to evaluate safety and efficacy of Atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer (R-IMMUNE).
| Cancers | |
|---|---|
| Organ | Rectum |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1b |
| Academic trial | Oui |
| Sponsor | GHdC |
| EudraCT Identifier | 2016-004526-41 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03127007 |
| Inclusion criteria | Rectal adenocarcinoma requiring preoperative radiotherapy |
| Last update |